ALPS ADVISORS INC

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1376113 Denver, CO

Position in RIGL

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,488,633

+$566,029 QoQ

Shares Held

38,053

+11.5% QoQ

Ownership

0.204%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#56

of 156 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. RIGL ranks #49 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	315,335	$17,680,833
2	APGE	Apogee Therapeutics, Inc.	62,523	$8,298,677
3	CGON	CG Oncology, Inc.	89,218	$6,338,938
4	XENE	Xenon Pharmaceuticals Inc.	97,610	$5,891,739
5	ORKA	Oruka Therapeutics, Inc.	61,014	$5,806,702
6	DNTH	Dianthus Therapeutics, Inc. /DE/	55,281	$5,388,791
7	TVTX	Travere Therapeutics, Inc.	93,981	$5,339,060
8	DFTX	Definium Therapeutics, Inc.	110,388	$5,192,651

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,488,633	38,053	+11.5%	Shares	Defined	2026-07-29
2026-03-31	$922,604	34,120	+26.3%	Shares	Defined	2026-05-08
2025-12-31	$1,157,009	27,014	+32.4%	Shares	Defined	2026-02-12
2025-09-30	$578,016	20,403	+55.7%	Shares	Defined	2025-11-05
2025-03-31	$235,669	13,100	-8.0%	Shares	Defined	2025-04-30
2024-12-31	$239,516	14,240	-84.9%	Shares	Defined	2025-02-13
2022-09-30	$111,324	94,343	-7.6%	Shares	Defined	2022-11-14
2022-06-30	$115,333	102,065	-42.2%	Shares	Defined	2022-08-15
2022-03-31	$527,579	176,448	-10.8%	Shares	Defined	2022-05-16
2021-12-31	$524,445	197,904	-8.1%	Shares	Defined	2022-02-09
2020-09-30	$517,041	215,434	-6.3%	Shares	Defined	2020-11-05
2020-06-30	$420,834	229,964	-24.5%	Shares	Defined	2020-08-05
2020-03-31	$475,371	304,725	—	Shares	Defined	2020-05-06
No filing history on record for this holder in this stock.